Back to Results
First PageMeta Content
Pharmacology / Cancer organizations / Biomarkers / Clinical trial / Imaging biomarker / Cancer and Leukemia Group B / Medicine / Health / Epidemiology


Overview of the ETCTN April 21, 2014 Percy Ivy, MD ETCTN and ETCTN-Phase 1 Program Director Associate Chief, Investigational Drug Branch Cancer Therapy Evaluation Program
Add to Reading List

Document Date: 2014-06-09 20:16:56


Open Document

File Size: 1,85 MB

Share Result on Facebook

Company

Therapeutics 1 Special Emphasis Panel New Drug Company / Silos (14 sites) Integrated Network (10 sites) Centralized Support Limited / Sample Acquisition Limited / /

Event

FDA Phase / /

Facility

Single pipeline / /

IndustryTerm

Cancer Treatment / imaging / Cancer Therapy / /

MedicalCondition

tumor / cancer / /

MedicalTreatment

Cancer Therapy / /

Organization

Translational NCI Project Team Division / Central Institutional Review Board / /

Person

Investigational Drug / Percy Ivy / /

Position

Program Director / Proposed Molecular Characterization Occasional Expected Team Science Infrequent Required Tackle / Team Member / Director Associate / Chief / /

Product

Investigational Drug / /

Technology

treating cancer / DCTD Reviews Cooperative Research and Development Program-Signed Senior Advisory Committee Protocol development Protocol / Pharmacokinetics / Drug Development / /

SocialTag